237 related articles for article (PubMed ID: 32980961)
21. Imaging-Based Surrogate Markers of Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinoma: A Local Perspective.
AlGharras A; Kovacina B; Tian Z; Alexander JW; Semionov A; van Kempen LC; Sayegh K
Can Assoc Radiol J; 2020 May; 71(2):208-216. PubMed ID: 32062999
[TBL] [Abstract][Full Text] [Related]
22. Associations between clinical data and computed tomography features in patients with epidermal growth factor receptor mutations in lung adenocarcinoma.
Cao Y; Xu H; Liao M; Qu Y; Xu L; Zhu D; Wang B; Tian S
Int J Clin Oncol; 2018 Apr; 23(2):249-257. PubMed ID: 28988295
[TBL] [Abstract][Full Text] [Related]
23. [Evaluate the value of (18)F-FDG PET-CT imaging in predicting the mutationsin epidermal growth factor receptor in lung adenocarcinoma].
Ding CY; Yang WP; Guo Z; Sun J; Li YY; Li TR
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):528-531. PubMed ID: 28728300
[No Abstract] [Full Text] [Related]
24. CT spectral parameters and serum tumour markers to differentiate histological types of cancer histology.
Jia Y; Xiao X; Sun Q; Jiang H
Clin Radiol; 2018 Dec; 73(12):1033-1040. PubMed ID: 30115364
[TBL] [Abstract][Full Text] [Related]
25. Correlation between dual-energy spectral CT imaging parameters and pathological grades of non-small cell lung cancer.
Lin LY; Zhang Y; Suo ST; Zhang F; Cheng JJ; Wu HW
Clin Radiol; 2018 Apr; 73(4):412.e1-412.e7. PubMed ID: 29221718
[TBL] [Abstract][Full Text] [Related]
26. Analysis of CT features and quantitative texture analysis in patients with lung adenocarcinoma: a correlation with EGFR mutations and survival rates.
Sacconi B; Anzidei M; Leonardi A; Boni F; Saba L; Scipione R; Anile M; Rengo M; Longo F; Bezzi M; Venuta F; Napoli A; Laghi A; Catalano C
Clin Radiol; 2017 Jun; 72(6):443-450. PubMed ID: 28258739
[TBL] [Abstract][Full Text] [Related]
27. [Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma].
Yang CS; Chen WD; Gong GZ; Li ZJ; Qiu QT; Yin Y
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):282-287. PubMed ID: 31014053
[No Abstract] [Full Text] [Related]
28. Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas.
Liu Y; Kim J; Balagurunathan Y; Li Q; Garcia AL; Stringfield O; Ye Z; Gillies RJ
Clin Lung Cancer; 2016 Sep; 17(5):441-448.e6. PubMed ID: 27017476
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Quantitative Dual-Energy Computed Tomography Parameters for Differentiation of Parotid Gland Tumors.
Wang Y; Hu H; Ban X; Jiang Y; Su Y; Yang L; Shi G; Yang L; Han R; Duan X
Acad Radiol; 2024 May; 31(5):2027-2038. PubMed ID: 37730491
[TBL] [Abstract][Full Text] [Related]
30. A clinically practical radiomics-clinical combined model based on PET/CT data and nomogram predicts EGFR mutation in lung adenocarcinoma.
Chang C; Zhou S; Yu H; Zhao W; Ge Y; Duan S; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Yan H; Sun X; Xie W
Eur Radiol; 2021 Aug; 31(8):6259-6268. PubMed ID: 33544167
[TBL] [Abstract][Full Text] [Related]
31. Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning.
Wang S; Shi J; Ye Z; Dong D; Yu D; Zhou M; Liu Y; Gevaert O; Wang K; Zhu Y; Zhou H; Liu Z; Tian J
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30635290
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors of EGFR-mutated metastatic adenocarcinoma of lung.
Ng KS; King Sun C; Boom Ting K; Ting Kun AY
Eur J Radiol; 2020 Feb; 123():108780. PubMed ID: 31846863
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.
Wang D; Zhang M; Gao X; Yu L
PLoS One; 2016; 11(6):e0158307. PubMed ID: 27336755
[TBL] [Abstract][Full Text] [Related]
34. Dual-energy dynamic CT of lung adenocarcinoma: correlation of iodine uptake with tumor gene expression.
Yanagawa M; Morii E; Hata A; Fujiwara M; Gyobu T; Ueda K; Honda O; Tomiyama N
Eur J Radiol; 2016 Aug; 85(8):1407-13. PubMed ID: 27423680
[TBL] [Abstract][Full Text] [Related]
35. [Differential diagnosis of pure ground glass nodules in lung with spectral CT imaging].
Yu R; Hou JP; Ni XQ; Ya Y; Fan GH
Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(45):3742-3747. PubMed ID: 34856703
[No Abstract] [Full Text] [Related]
36. Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma.
Zou J; Lv T; Zhu S; Lu Z; Shen Q; Xia L; Wu J; Song Y; Liu H
Thorac Cancer; 2017 May; 8(3):260-270. PubMed ID: 28383802
[TBL] [Abstract][Full Text] [Related]
37. Correlation between EGFR mutation status and F
Zhu L; Yin G; Chen W; Li X; Yu X; Zhu X; Jiang W; Jia C; Chen P; Zhang Y; Lu D; Yu L; Li X; Xu W
Thorac Cancer; 2019 Apr; 10(4):659-664. PubMed ID: 30776196
[TBL] [Abstract][Full Text] [Related]
38. Relationship between EGFR mutation and computed tomography characteristics of the lung in patients with lung adenocarcinoma.
Qiu X; Yuan H; Sima B
Thorac Cancer; 2019 Feb; 10(2):170-174. PubMed ID: 30516345
[TBL] [Abstract][Full Text] [Related]
39. Correlation with Spectral CT Imaging Parameters and Occult Lymph Nodes Metastases in Sufferers with Isolated Lung Adenocarcinoma.
Liu Y; Nie Y
Contrast Media Mol Imaging; 2022; 2022():5472446. PubMed ID: 35833081
[TBL] [Abstract][Full Text] [Related]
40. Radiological and Clinical Features associated with Epidermal Growth Factor Receptor Mutation Status of Exon 19 and 21 in Lung Adenocarcinoma.
Shi Z; Zheng X; Shi R; Song C; Yang R; Zhang Q; Wang X; Lu J; Yu Y; Liu Q; Jiang T
Sci Rep; 2017 Mar; 7(1):364. PubMed ID: 28336963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
